Table 1.
Summary of SNPs by levels of statistical significance in the final combined analysis, ER-negative and ER-positive case patients*
| P value cutoff | All invasive case patients | ER-positive case patients | ER-negative case patients | |||
|---|---|---|---|---|---|---|
| Observed | Expected | Observed | Expected | Observed | Expected | |
| < 5x10-8 | 28 | 0 | 0 | 0 | 1 | 0 |
| < 1x10-7 | 31 | 0 | 0 | 0 | 3 | 1 |
| < 1x10-6 | 34 | 10 | 2 | 10 | 25 | 10 |
| < 1x10-5 | 134 | 97 | 75 | 98 | 292 | 100 |
| < 1x10-4 | 928 | 971 | 894 | 975 | 1164 | 1002 |
| < 1x10-3 | 9375 | 9707 | 10 509 | 9752 | 11 032 | 10 020 |
* ER = estrogen receptor; SNP = single nucleotide polymorphism.